雜志介紹

Journal Of Clinical Lipidology雜志介紹

《Journal Of Clinical Lipidology》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱臨床脂質(zhì)學(xué)雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.6，最新CiteScore 指數(shù)為7。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Recurrence for patients with first episode of hypertriglyceridemia-induced acute pancreatitis: A prospective cohort study

  Author: Ding, Ling; Guan, Langyi; Li, Xueyang; Xu, Xin; Zou, Yaoyu; He, Cong; Hu, Yi; Wan, Jianhua; Huang, Xin; Lei, Yupeng; He, Wenhua; Xia, Liang; Xiong, Huifang; Luo, Lingyu; Lu, Nonghua; Zhu, Yin

• Clinical features, molecular characteristics, and treatments of a Chinese girl with sitosterolemia: A case report and literature review

  Author: Xueying Su, Yongxian Shao, Yunting Lin, Xiaoyuan Zhao, Wen Zhang, Minyan Jiang, Yonglan Huang, Chunhua Zeng, Li Liu, Xiuzhen Li

• Small HDL subclass is associated with coronary plaque stability: An optical coherence tomography study in patients with coronary artery disease

  Author: Xuedong Wang, Xinxin Liu, Zulong Xie, Jinwei Tian, Xingtao Huang, Ruoxi Zhang, Shuyuan Chen, Jingbo Hou, Bo Yu

• Severe aortic valve stenosis in a 14-year-old boy with sitosterolemia

  Author: Yu Wang, Yuan-Lin Guo, Qiu-Ting Dong, Jian-Jun Li

英文介紹

Journal Of Clinical Lipidology雜志英文介紹

Because the scope of clinical lipidology is broad, the topics addressed by the Journal are equally diverse. Typical articles explore lipidology as it is practiced in the treatment setting, recent developments in pharmacological research, reports of treatment and trials, case studies, the impact of lifestyle modification, and similar academic material of interest to the practitioner. While preference is given to material of immediate practical concern, the science that underpins lipidology is forwarded by expert contributors so that evidence-based approaches to reducing cardiovascular and coronary heart disease can be made immediately available to our readers. Sections of the Journal will address pioneering studies and the clinicians who conduct them, case studies, ethical standards and conduct, professional guidance such as ATP and NCEP, editorial commentary, letters from readers, National Lipid Association (NLA) news and upcoming event information, as well as abstracts from the NLA annual scientific sessions and the scientific forums held by its chapters, when appropriate.